Skip to content

REGENERON PHARMACEUTICALS, INC.: filings

Every REGENERON PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 65 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-30fiscal Q2 2026421230000872589-26-000025
10-Q2026-04-29fiscal Q1 202642890000872589-26-000016
10-K2026-02-04fiscal FY 2025501340000872589-26-000008
10-Q2025-10-28fiscal Q3 2025421270000872589-25-000028
10-Q2025-08-01fiscal Q2 2025421230000872589-25-000019
10-Q2025-04-29fiscal Q1 202542890001804220-25-000022
10-K2025-02-05fiscal FY 2024501340001804220-25-000011
10-Q2024-10-31fiscal Q3 2024421270001804220-24-000040
10-Q2024-08-01fiscal Q2 2024421230001804220-24-000028
10-Q2024-05-02fiscal Q1 202442890001804220-24-000017
10-K2024-02-05fiscal FY 2023501340001804220-24-000009
10-Q2023-11-02fiscal Q3 2023421270001804220-23-000031
10-Q2023-08-03fiscal Q2 2023421230001804220-23-000023
10-Q2023-05-04fiscal Q1 202342890001804220-23-000016
10-K2023-02-06fiscal FY 2022481280001804220-23-000008
10-Q2022-11-03fiscal Q3 2022441330001804220-22-000031
10-Q2022-08-03fiscal Q2 2022411210001804220-22-000023
10-Q2022-05-04fiscal Q1 202241870001804220-22-000015
10-K2022-02-07fiscal FY 2021451230001804220-22-000007
10-Q2021-11-04fiscal Q3 2021411250001804220-21-000033
10-Q2021-08-05fiscal Q2 2021401170001804220-21-000025
10-Q2021-05-06fiscal Q1 202140850001804220-21-000017
10-K2021-02-08fiscal FY 2020431500001804220-21-000008
10-Q2020-11-05fiscal Q3 2020391190001804220-20-000030
10-Q2020-08-05fiscal Q2 2020391150001804220-20-000022
10-Q2020-05-05fiscal Q1 202039830001804220-20-000011
10-K2020-02-07fiscal FY 2019491600001532176-20-000008
10-Q2019-11-05fiscal Q3 2019391190001532176-19-000034
10-Q2019-08-06fiscal Q2 2019391150001532176-19-000026
10-Q2019-05-07fiscal Q1 201939830001532176-19-000017
10-K2019-02-07fiscal FY 2018481600001532176-19-000009
10-Q2018-11-06fiscal Q3 2018391090001532176-18-000036
10-Q2018-08-02fiscal Q2 2018381070001532176-18-000028
10-Q2018-05-03fiscal Q1 201838790001532176-18-000020
10-K2018-02-08fiscal FY 2017441500001532176-18-000013
10-Q2017-11-08fiscal Q3 2017361000001532176-17-000034
10-Q2017-08-03fiscal Q2 2017361000001532176-17-000027
10-Q2017-05-04fiscal Q1 201736740001532176-17-000017
10-K2017-02-09fiscal FY 2016431470001532176-17-000008
10-Q2016-11-04fiscal Q3 201635960001532176-16-000082
10-Q2016-08-04fiscal Q2 201635960001532176-16-000067
10-Q2016-05-05fiscal Q1 201635720001532176-16-000055
10-K2016-02-11fiscal FY 2015441500001532176-16-000045
10-Q2015-11-04fiscal Q3 2015371150001532176-15-000037
10-Q2015-08-04fiscal Q2 2015371270001532176-15-000029
10-Q2015-05-07fiscal Q1 2015381120001532176-15-000020
10-K2015-02-12fiscal FY 2014431470001532176-15-000008
10-Q2014-11-04fiscal Q3 2014371040001532176-14-000046
10-Q2014-08-05fiscal Q2 2014371040001532176-14-000035
10-Q2014-05-08fiscal Q1 201437780001532176-14-000022
10-K2014-02-13fiscal FY 2013421440001532176-14-000008
10-Q2013-11-05fiscal Q3 201336990001532176-13-000030
10-Q2013-08-06fiscal Q2 201336990001532176-13-000022
10-Q2013-05-03fiscal Q1 201336740001532176-13-000008
10-K2013-02-15fiscal FY 2012411280001532176-13-000004
10-Q2012-10-24fiscal Q3 2012361000001532176-12-000004
10-Q2012-07-25fiscal Q2 2012361020001206774-12-003062
10-Q2012-04-26fiscal Q1 201236750001206774-12-001689
10-K2012-02-21fiscal FY 2011331020001206774-12-000709
10-Q2011-10-27fiscal Q3 201131840001206774-11-002300
10-Q2011-07-28fiscal Q2 201131840001206774-11-001639
10-Q2011-05-03fiscal Q1 201129620001206774-11-001105
10-K2011-02-17fiscal FY 201028740001206774-11-000263
10-Q2010-10-28fiscal Q3 201027720001206774-10-002228
10-Q2010-07-28fiscal Q2 201027720001206774-10-001689

Inspect the source

Entity
REGENERON PHARMACEUTICALS, INC. / CIK 0000872589
Captured
2026-09-19T11:15:01.411Z
SEC response SHA-256
8ac8537cd8b5e571e7f527aae3e223c6a7cdab1260fd8035e278ac184b4901b4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000872589.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))